Baron & Budd Finalizes $774 Million Settlement With Albertsons in Nationwide Opioid Litigation

Baron & Budd announced the finalization of a $774 million nationwide settlement with Albertsons Companies, Inc., resolving allegations regarding the company’s role in the opioid epidemic. The funds will be distributed to states, counties, municipalities, and Native American tribes to support recovery efforts. This settlement, combined with previous agreements, brings the total national recovery amount to over $60 billion.

Albertsons, operating over 1,700 pharmacies, allegedly failed to fulfill its “corresponding responsibility” obligations under federal and state law, which require pharmacies to identify and address suspicious prescriptions. Plaintiffs also claimed Albertsons’ distribution practices did not adequately monitor and report suspicious opioid orders. Russell Budd, President and Managing Shareholder of Baron & Budd, emphasized the settlement’s importance in addressing the harm caused by the opioid crisis.

The opioid crisis, fueled by widespread improper distribution of painkillers, has led to increased addiction, overdose deaths, and other harms. This settlement is part of a larger national effort to provide resources for recovery and long-term healing, with Baron & Budd playing a leading role in opioid litigation for over a decade.

(Source：Financialcontent)